Influenza vaccine production for the U.S. market

Lauren M. Smith, Gigi Kwik Gronvall

Research output: Contribution to journalArticle

Abstract

Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalBiosecurity and Bioterrorism
Volume7
Issue number3
DOIs
StatePublished - Sep 1 2009

    Fingerprint

ASJC Scopus subject areas

  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Management, Monitoring, Policy and Law

Cite this